Beranda › Neuroblastoma › Minnesota
Uji klinis Neuroblastoma di Minnesota
9 studi untuk Neuroblastoma mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
Menerima pesertaFase 3
Hingga usia 30 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06172296Biomarkers of Resiliency In Childhood Cancer Surgery
- Mayo Clinic, Rochester
Menerima pesertaStudi observasional
Usia 3 hingga 25 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06674811Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Children's Hospital and Clinics of Minnesota, Minneapolis
Menerima pesertaFase 2
Hingga usia 22 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT02559778Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
Menerima pesertaFase 3
365 Days – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- University of Minnesota/Masonic Cancer Center, Minneapolis
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Children's Hospital and Clinics of Minnesota, Minneapolis
Menerima pesertaFase 2
12 Months – 21 Years · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05489887Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital and Clinics of Minn, Minneapolis
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT04901702Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- Masonic Cancer Center, University of Minnesota, Minneapolis
Menerima pesertaFase 2
Hingga usia 30 · Semua jenis kelamin · Diperbarui 21 Okt 2025 · NCT02605421International PPB/DICER1 Registry
- Children's Minnesota, Minneapolis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
0 Minutes – 100 Years · Semua jenis kelamin · Diperbarui 30 Jan 2025 · NCT03382158Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.